San Francisco, Oct 15 The
global clinical
decision support systems (CDSS) market size is estimated to reach
USD 791.25 million by 2024, according to a new report by Grand View Research,
Inc., progressing at a CAGR of 6.7% during the forecast period. Surging demand
for quality care is one of the primary factors augmenting the market. Constant
lookout for reliable technology solutions by care providers is also expected to
work in favor of the market. Growing interest in enhanced medical care and
efficient decision-making is projected to fuel adoption of CDSS and EHR.
CDSS
industry includes products that provide knowledge-based and evidence-based
solutions to practitioners. Decision support in critical health situation
proves to be of significant importance. Furthermore, these systems analyze
patient medical records and provide a list of possible solutions from which the
most appropriate is to be selected.
Easy
compatibility and interoperability of systems with different platforms have
enhanced growth prospects of the market. Collaborative efforts of researchers
and software developers to make medical knowledge available to users are
anticipated to contribute towards lucrative revenue generation over the
forecast period. Furthermore, collaborations intended by market participants
for availing licensed product platforms for CDSS is likely to influence the
growth of the market positively.
Browse
full research report on Clinical
Decision Support Systems (CDSS) Market:
www.grandviewresearch.com/industry-analysis/clinical-decision-support-system-market
Further key findings from the study suggest:
- Standalone
CDSS accounted for the largest share of market revenue in 2016 owing to
its low cost. The segment is estimated to hold approximately 36.0% of the
overall market by 2024
- The CDSS
integrated with CPOE segment is poised experience noteworthy growth over
the coming years due to rapid adoption of healthcare IT solutions by
clinicians
- Drug allergy
alerts made the highest contribution to market revenue generation in 2016.
The segment is expected to expand at a CAGR of 6.4% between 2017 and 2024
- Domicile of a
large number of key players and high adoption of advanced technologies are
anticipated to contribute to the dominance of North America. However, Asia
Pacific is estimated to witness the highest CAGR of 7.8% during the
forecast period
- Key players
operating in this industry include Agfa healthcare; McKesson Corporation;
NextGen Healthcare Information Systems; Medical Information Technology
Inc; Carestream Health Inc.; AthenaHealth; Philips Healthcare; Wolters
Kluwer NU; Cerner Corporation; and Siemens Healthineers. Collaboration
with IT companies to develop innovative products and enhance existing
platforms is likely to help key players to stay ahead in the market.
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/healthcare-it
Grand
View Research has segmented global clinical decision support systems (CDSS)
market on the basis of product, application, delivery mode, component, and
region:
Clinical
Decision Support Systems Product Outlook (Revenue, USD Million, 2013 -
2024)
- Standalone
CDSS
- Integrated
CPOE with CDSS
- Integrated
E.H.R. with CDSS
- Integrated
CDSS with CPOE & E.H.R.
Clinical
Decision Support Systems Application Outlook (Revenue, USD Million, 2013 -
2024)
- Drug-drug
interactions
- Drug allergy
alerts
- Clinical
reminders
- Clinical
guidelines
- Drug dosing
support
- Others
Clinical
Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2013 -
2024)
- Web Delivery
- Cloud
Delivery
- On Premises
Delivery
Clinical
Decision Support Systems Component Outlook (Revenue, USD Million, 2013 - 2024)
- Hardware
- Software
- Services
Clinical
Decision Support Systems Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East
and Africa (MEA)
- South Africa
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-clinical-decision-support-system-cdss-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment